Bain Capital Life Sciences Investors, LLC Portfolio Holdings

Bain Capital Life Sciences Investors, LLC

  • $370 Million
  • Q4 2024

Bain Capital Life Sciences Investors, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $370 Million distributed in 26 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Nuvalent, Inc. with a value of $113M, Pharvaris N.V. with a value of $63.3M, Savara Inc with a value of $44.7M, Olema Pharmaceuticals, Inc. with a value of $43.6M, and Annexon, Inc. with a value of $26.9M.

Examining the 13F form we can see an decrease of $187M in the current position value, from $557M to 370M.

Bain Capital Life Sciences Investors, LLC is based out at Boston, MA

Below you can find more details about Bain Capital Life Sciences Investors, LLC portfolio as well as his latest detailed transactions.

Portfolio value $370 Million
Healthcare: $370 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 26
  • Current Value $370 Million
  • Prior Value $557 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 2 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email